Tatva Chintan Pharma Chem Limited

Web: tatvachintan.com NSE: TATVA BSE: 543321 SECTOR: Chemicals - Chemicals & Petrochemicals | Add Note | View Notes

1740 21(-1%)

Near 52W High of 1838

Volume

27k as on 22, Jun

Open

865

High

865

Low

852

1,761

VWAP

1,200

52 Week High

1,838

52 Week Low

976

Viand Research Rating

Quality Score

70/100

Growth Score

77/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,070

No. of Shares

2.34

P/E

151.25

P/B

2.79

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

1.84

ROCE

Profit Growth

Listing Date

29-Jul-21

Rank/Sector Rank

#839/-

Promoter Holding

72.02%

FII Holding

3.93%

DII Holding

3.11%

Price Chart

Price Performance

1 Week1%

1 Month0%

3 Months6%

6 Months9%

1 Year9%

YTD9%

Moving Average

5 Day SMA1,192

10 Day SMA1,178

20 Day SMA1,177

30 Day SMA1,205

50 Day SMA1,239

61 Day SMA1,219

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,231	1,201	1,218	1,252
Resistance 2	1,218	1,199	1,209	1,229
Resistance 1	1,206	1,196	1,203	1,227
Pivot Point	1,193	1,194	1,193	1,204
Support 1	1,181	1,192	1,183	1,202
Support 2	1,168	1,189	1,178	1,178
Support 3	1,156	1,187	1,168	1,177

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SOLARINDS	1,79,985	19890	3%	0%	54%	40%	89	57.9	0.24	1737
2	PIDILITIND	1,60,082	1573	3%	5%	17%	6%	62	57.9	0.04	2471
3	SRF	75,242	2538	3%	1%	3%	13%	0	57.9	0.36	1835
4	COROMANDEL	57,389	1945	0%	3%	2%	14%	0	57.9	0.12	1898
5	LINDEINDIA	54,113	6345	4%	5%	10%	2%	0	57.9	0.02	551
6	FACT	51,390	794	6%	2%	1%	18%	0	57.9	2.95	-40
7	FLUOROCHEM	49,262	4484	3%	3%	41%	16%	0	57.9	0.35	574
8	UPL	47,265	560	0%	2%	10%	17%	0	57.9	0.68	2220
9	NAVINFLUOR	43,142	8411	3%	3%	38%	80%	0	57.9	0.01	488
10	PIIND	36,564	2410	7%	3%	17%	34%	0	57.9	0.01	1435
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(-7.21) 72.02%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%
FIIs	(0.11) 3.93%	(-0.41) 3.81%	(0.81) 4.17%	(0.11) 3.40%	(0.01) 3.26%	(-0.11) 3.30%	(0.01) 3.36%	(0.01) 3.33%	(-0.31) 3.37%	(-0.61) 3.65%	(-0.21) 4.21%	(1.21) 4.40%	(-0.41) 3.19%	(-0.21) 3.54%	(0.21) 3.74%	(0.11) 3.59%	(0.51) 3.53%	(0.11) 3.05%	(-0.61) 2.91%	(0.01) 3.53%
DIIs	(0.11) 3.11%	(-0.31) 2.99%	(-0.61) 3.32%	(-1.21) 3.87%	(-0.41) 5.11%	(-0.91) 5.46%	(-0.51) 6.34%	(-3.81) 6.83%	(-2.21) 10.64%	(-0.21) 12.84%	(-0.71) 13.06%	(2.71) 13.78%	(-0.61) 11.07%	(0.21) 11.71%	(0.41) 11.52%	(0.41) 11.17%	(2.61) 10.75%	(0.31) 8.13%	(0.51) 7.87%	(0.01) 7.36%
Public	20.94%	21.16%	20.49%	20.72%	19.60%	19.21%	18.27%	17.81%	13.97%	11.49%	10.72%	9.79%	6.56%	5.59%	5.58%	6.08%	6.55%	9.65%	10.05%	9.94%
No. of Shareholders	64,921	66,842	68,657	73,331	76,792	78,393	79,009	79,623	73,912	73,730	74,519	74,628	70,799	70,037	71,958	76,267	84,358	89,930	88,311	89,438

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	167	134	131	124	117	108	86	83	105	98	84	97	114	125	121	90.09	88.4	98.53	104.67	123.62	106.83
Sales Growth % (YoY)	43%	24.4%	52.9%	48%	10.8%	9.8%	2%	-13.6%	-7.8%	-21.1%	-30.2%	7.3%	29.4%	26.4%	15%	-27.1%	-17.2%	-9.3%	30.6%	105.9%	107.3%
Sales Growth % (QoQ)	24.6%	2.3%	5.6%	6%	8.3%	25.6%	3.6%	-21%	7.1%	16.7%	-13.4%	-14.9%	-8.8%	3.3%	34.3%	1.9%	-10.3%	-5.9%	-15.3%	15.7%	-
Expenses	135	106	106	101	100	99	79	78	93	83	73	76	93	108	103	78.91	73.19	76.54	80.71	88.18	81
Operating Profit	32	28	25	22	17	9	7	6	13	16	11	20	21	16	18	11.18	15.21	21.99	23.96	35.44	25.83
OPM %	19	21	19	18	15	8	8	7	12	16	13	21	19	13	15	12.41	17.21	22.32	22.89	28.67	24.18
Other Income	1	0	2	1	1	1	0	0	1	5	1	1	1	-3	1	1.55	1.88	0.31	4.57	3.25	1.77
Interest	2	1	0	1	0	0	0	0	0	0	0	3	3	3	2	1.36	1.06	1.18	0.99	1.22	1.44
Depreciation	11	10	9	9	9	7	7	7	7	6	7	7	6	3	2	2.31	2.33	2.15	2.08	2.06	1.9
Profit before tax	21	17	18	14	9	2	0	-1	7	14	5	11	13	8	14	9.06	13.7	18.97	25.46	35.41	24.26
Tax %	24	38	14	27	27	49	-165	-34	24	30	34	31	29	-117	18	21.52	28.47	7.75	10.45	8.47	4.58
Net Profit	16	10	15	10	7	1	0	-1	5	10	3	8	10	17	12	7.11	9.8	17.51	22.81	32.41	23.15
Net Profit Growth % (QoQ)	60%	-33.3%	50%	42.9%	600%	100%	100%	-120%	-50%	233.3%	-62.5%	-20%	-41.2%	41.7%	68.8%	-27.4%	-44%	-23.2%	-29.6%	40%	-
Net Profit Growth % (YoY)	128.6%	900%	100%	1100%	40%	-90%	-100%	-112.5%	-50%	-41.2%	-75%	12.5%	2%	-2.9%	-47.4%	-78.1%	-57.7%	-	-	-	-
TTM Net Profit	51	42	33	18	7	5	14	17	26	31	38	47	46.11	45.91	46.42	57.23	82.53	95.88	78.37	55.56	0
EPS in Rs	6.83	4.41	6.49	4.24	2.84	0.44	0.06	-0.28	2.23	4.11	1.48	3.33	4.29	7.65	5.24	3.21	4.42	7.9	10.29	14.62	11.52

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Sales	506	383	394	424	434	300	263	206	136
Sales Growth %	32.2%	-2.7%	-7.1%	-2.3%	44.4%	14.1%	27.6%	51.9%	-
Expenses	413	348	325	363	325	234	208	172	113
Operating Profit	93	35	69	61	109	67	55	34	23
OPM %	18	9	17	14	25	22	21	17	17
Other Income	4	2	7	2	9	5	1	1	1
Interest	3	2	7	9	5	4	4	4	3
Depreciation	37	28	26	10	8	7	5	4	3
Profit before tax	57	8	44	45	104	61	48	27	19
Tax %	26	25	30	-2	8	14	21	25	35
Net Profit	42	6	30	45	96	52	38	21	12
Net Profit Growth %	600%	-80%	-33.3%	-53.1%	84.6%	36.8%	81%	75%	-
EPS in Rs	17.98	2.44	12.97	20.52	43.25	26.02	47.03	25.56	15.3
Dividend Payout %	11	41	15	10	5	19	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Cash from Operating Activity	31	25	98	28	20	20	25	7	13
Cash from Investing Activity	-116	-65	-121	-101	-197	-21	-40	-17	-30
Cash from Financing Activity	79	17	31	38	235	-5	10	17	7
Net Cash Flow	-5	-24	8	-36	59	-6	-5	8	-10

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Equity Capital	23	23	23	23	23	22	22	20	8	8	8
Reserves	758	731	715	714	714	493	451	146	110	72	51
Borrowings	120	83	36	15	14	170	120	90	91	77	56
Other Liabilities	102	70	61	54	67	74	65	59	41	31	28
Total Liabilities	1004	908	836	807	819	759	658	315	249	188	144
Fixed Assets	611	515	526	425	427	196	160	120	111	67	57
CWIP	23	80	27	114	77	231	51	10	5	6	10
Investments	4	0	0	0	10	0	0	0	0	0	1
Other Assets	365	312	283	268	305	332	447	185	133	115	76
Total Assets	1004	908	836	807	819	759	658	315	249	188	144

Delivery

Delivery Data: TATVA

#	Date	1375 34% 1838	Value (Cr)	Q/T 17	Del 36	Del 34
1	22-Sep	1744	10	9	39	4
2	21-Sep	1761	8	9	46	4
3	18-Sep	1770	16	11	43	7
4	17-Sep	1710	15	8	37	6
5	16-Sep	1647	18	9	36	6
6	15-Sep	1547	7	7	58	4
7	11-Sep	1609	8	8	57	4
8	10-Sep	1659	16	8	35	6
9	9-Sep	1688	6	7	50	3
10	8-Sep	1680	7	8	47	3
11	7-Sep	1696	15	9	52	8
12	4-Sep	1678	14	9	53	8
13	3-Sep	1596	3	7	50	2
14	2-Sep	1617	7	8	41	3
15	1-Sep	1605	6	10	61	4
16	31-Aug	1627	5	9	41	2
17	28-Aug	1630	5	7	53	2
18	27-Aug	1599	20	10	32	6
19	26-Aug	1606	4	6	49	2
20	25-Aug	1581	6	9	54	3
21	24-Aug	1606	6	8	50	3
22	21-Aug	1616	7	9	54	4
23	20-Aug	1638	11	11	49	5
24	19-Aug	1648	6	9	45	2
25	18-Aug	1670	14	10	47	7
26	17-Aug	1686	12	10	45	5
27	14-Aug	1717	6	8	47	3
28	13-Aug	1710	6	8	49	3
29	12-Aug	1732	9	8	43	4
30	11-Aug	1786	7	9	46	3
31	10-Aug	1776	13	9	44	6
32	7-Aug	1719	13	9	45	6
33	6-Aug	1731	6	9	46	3
34	5-Aug	1721	15	10	39	6
35	4-Aug	1766	10	8	41	4
36	3-Aug	1771	21	13	37	8
37	31-Jul	1788	32	13	39	12
38	30-Jul	1680	11	10	44	5
39	29-Jul	1744	15	12	31	5
40	28-Jul	1718	35	12	32	11
41	27-Jul	1800	43	14	39	17
42	24-Jul	1722	27	14	30	8
43	23-Jul	1701	49	14	22	11
44	22-Jul	1665	59	19	26	15
45	21-Jul	1685	285	18	12	33
46	20-Jul	1714	551	29	12	67
47	17-Jul	1428	18	10	45	8
48	16-Jul	1418	6	9	39	2
49	15-Jul	1385	8	10	43	4

Daily Market Cap

Date	Total Market Cap	Change	Chg %
22-Sep	4,070c	140c	3.57
17-Sep	3,930c	16c	0.40
10-Sep	3,946c	48c	1.24
07-Sep	3,898c	4c	0.09
04-Sep	3,901c	121c	3.21
03-Sep	3,780c	1c	0.03
01-Sep	3,781c	27c	0.71
31-Aug	3,808c	100c	2.69
27-Aug	3,708c	9c	0.24
26-Aug	3,700c	13c	0.34
25-Aug	3,687c	59c	1.57
24-Aug	3,746c	99c	2.59
21-Aug	3,845c	61c	1.57
19-Aug	3,907c	21c	0.54
18-Aug	3,928c	33c	0.83
17-Aug	3,960c	73c	1.80
14-Aug	4,033c	36c	0.89
13-Aug	4,069c	39c	0.97
12-Aug	4,030c	126c	3.03
11-Aug	4,156c	0	0

Stock Checklist

Price is above from 52 week high low average: 89%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 10 fund scheme(s) across 4 fund house(s) as of Sep26 · Total value ₹216 Cr · 2 increasing / 6 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Nippon India Mutual Fund	2	0.57%	-0.05%	168.1
ICICI Prudential Mutual Fund	4	0.33%	-0.05%	40.3
WhiteOak Capital Mutual Fund	2	0.49%	+0.29%	7.7
Motilal Oswal Mutual Fund	2	0.00%	-0.01%	0

Tatva Chintan Pharma Chem Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements